Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer

Fig. 2

Treatment schema and duration of the intralymphatic catheter patency in the individual patients. Black: Duration of treatment involving intralymphatic cell delivery; Grey: Intranodal delivery; White: Intradermal delivery. Arrows represent the timing of the individual courses of treatment (12 doses over 72 h of each course of intralymphatic cell delivery; 3 doses over 72 h per course of intradermal cell delivery; single injections per each course of intranodal delivery)

Back to article page